The role of endogenous glucocorticoids in lymphocyte development in melanocortin receptor 2-deficient mice

Biochemical and Biophysical Research Communications

Volumn 403, Issue 3-4, 2010, Pages 253-257

  Sato, Yoshinori ^a   Suzuki, Harumi ^a   Sato, Tsuyoshi ^b   Suda, Toshihiro ^c   Yoda, Tetsuya ^b   Iwakura, Yoichiro ^d   Chida, Dai ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Endogenous glucocorticoids; MC2R mice; T and B lymphopoiesis

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID; MELANOCORTIN 2 RECEPTOR;

ADRENAL INSUFFICIENCY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL MATURATION; CONTROLLED STUDY; ERYTHROCYTE COUNT; HEMATOPOIESIS; LYMPHOCYTE; LYMPHOCYTE COUNT; LYMPHOPOIESIS; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SPLEEN; STEADY STATE; THYMOCYTE; THYMUS;

ADRENAL INSUFFICIENCY; AGING; ANIMALS; APOPTOSIS; B-LYMPHOCYTES; BONE MARROW; CORTICOSTERONE; LYMPHOCYTE COUNT; LYMPHOPOIESIS; MALE; MICE; MICE, MUTANT STRAINS; RECEPTOR, MELANOCORTIN, TYPE 2; SPLEEN; T-LYMPHOCYTES;

ANIMALIA; MUS;

EID: 78650176596     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.11.002     Document Type: Article

References (34)

1. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 1995, 332:1351-1363.
2. Rhen T., Cidlowski J.A. Anti-inflammatory action of glucocorticoids - new mechanisms for old drugs. N. Engl. J. Med. 2005, 353:1711-1723.
3. Ashwell J.D., Lu F.W.M., Vacchio M.S. Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 2000, 18:309-345.
4. Savino W., Dardenne M. Neuroendocrine control of thymus physiology. Endocr. Rev. 2000, 21:412-443.
5. Jaffe H.L. The influence of the supradrenal gland on the thymus I. Regeneration of the thymus following double supradrenalectomy in the rat. J. Exp. Med. 1924, 40:325-342.
6. Pruett S., Padgett E. Thymus-derived glucocorticoids are insufficient for normal thymus homeostasis in the adult mouse. BMC Immunol. 2004, 5:24.
7. Purton J.F., Boyd R.L., Cole T.J., Godfrey D.I. Intrathymic T cell development and selection proceeds normally in the absence of glucocorticoid receptor signaling. Immunity 2000, 13:179-186.
8. Purton J.F., Zhan Y., Liddicoat D.R., Hardy C.L., Lew A.M., Cole T.J., Godfrey D.I. Glucocorticoid receptor deficient thymic and peripheral T cells develop normally in adult mice. Eur. J. Immunol. 2002, 32:3546-3555.
9. Brewer J.A., Khor B., Vogt S.K., Muglia L.M., Fujiwara H., Haegele K.E., Sleckman B.P., Muglia L.J. T-cell glucocorticoid receptor is required to suppress COX-2-mediated lethal immune activation. Nat. Med. 2003, 9:1318-1322.
10. Laakko T., Fraker P. Rapid changes in the lymphopoietic and granulopoietic compartments of the marrow caused by stress levels of corticosterone. Immunology 2002, 105:111-119.
11. Garvy B.A., King L.E., Telford W.G., Morford L.A., Fraker P.J. Chronic elevation of plasma corticosterone causes reductions in the number of cycling cells of the B lineage in murine bone marrow and induces apoptosis. Immunology 1993, 80:587-592.
12. Kieffer J.D., Ketchel M.M. Effects of adrenalectomy and antigenic stimulation on spleen weight in mice. Transplantation 1971, 11:45-49.
13. Igarashi H., Medina K.L., Yokota T., Rossi M.I.D., Sakaguchi N., Comp P.C., Kincade P.W. Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids. Int. Immunol. 2005, 17:501-511.
14. Chida D., Nakagawa S., Nagai S., Sagara H., Katsumata H., Imaki T., Suzuki H., Mitani F., Ogishima T., Shimizu C., Kotaki H., Kakuta S., Sudo K., Koike T., Kubo M., Iwakura Y. Melanocortin 2 receptor is required for adrenal gland development Steroidogenesis, and neonatal gluconeogenesis. Proc. Natl. Acad. Sci. USA 2007, 104:18205-18210.
15. Matsuwaki T., Nishihara M., Sato T., Yoda T., Iwakura Y., Chida D. Functional hypothalamic amenorrhea due to increased CRH tone in melanocortin receptor 2-deficient mice. Endocrinology 2010, 151:5489-5496.
16. Chida D., Sato T., Sato Y., Kubo M., Yoda T., Suzuki H., Iwakura Y. Characterization of mice deficient in Melanocortin 2 receptor on a B6/Balbc mix background. Mol. Cell Endocrinol. 2009, 300:32-36.
17. Chida D., Imaki T., Suda T., Iwakura Y. Involvement of corticotropin-releasing hormone- and interleukin (IL)-6-dependent proopiomelanocortin induction in the anterior pituitary during hypothalamic-pituitary-adrenal axis activation by IL-1alpha. Endocrinology 2005, 146:5496-5502.
18. Muglia L., Jacobson L., Dikkes P., Majzoub J.A. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need. Nature 1995, 373:427-432.
19. Jeffcoate W. Assessment of corticosteroid replacement therapy in adults with adrenal insufficiency. Ann. Clin. Biochem. 1999, 36:151-157.
20. Rothenberg E., Dionne C. Lineage plasticity and commitment in T-cell development. Immunol. Rev. 2002, 187:96-115.
21. Oliver A.M., Martin F., Gartland G.L., Carter R.H., Kearney J.F. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur. J. Immunol. 1997, 27:2366-2374.
22. Loder B.F., Mutschler B., Ray R.J., Paige C.J., Sideras P., Torres R., Lamers M.C., Carsetti R. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 1999, 190:75-90.
23. Hardy R.R., Carmack C.E., Shinton S.A., Kemp J.D., Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 1991, 173:1213-1225.
24. Pazirandeh A., Jondal M., Okret S. Glucocorticoids delay age-associated thymic involution through directly affecting the thymocytes. Endocrinology 2004, 145:2392-2401.
25. Miller W.L., Tyrrell J.B. The adrenal cortex. Endocrinology and Metabolism 1995, 555-711. McGraw Hill, New York. P. Fehlig, J.D. Baxter, L.A. Frohman (Eds.).
26. Catania A. The melanocortin system in leukocyte biology. J. Leukoc. Biol. 2007, 81:383-392.
27. Karalis K., Muglia L.J., Bae D., Hilderbrand H., Majzoub J.A., RH C. The immune system. J. Neuroimmunol. 1997, 72:131-136.
28. + metabolism. Proc. Natl. Acad. Sci. USA 1998, 95:9424-9429.
29. Valverde M.A., Parker M.G. Classical and novel steroid actions: a unified but complex view. Trends Biochem. Sci. 2002, 27:172-173.
30. Hammes S.R., Levin E.R. Extranuclear steroid receptors: nature and actions. Endocr. Rev. 2007, 28:726-741.
31. Löwenberg M., Van den Brink A.P., Hommes D.W. Glucocorticoid signaling: a nongenomic mechanism for T-cell immunosuppression. Trends Mol. Med. 2007, 13:158-163.
32. Qiao S., Okret S., Jondal M. Thymocyte-synthesized glucocorticoids play a role in thymocyte homeostasis and are down-regulated by adrenocorticotropic hormone. Endocrinology 2009, 150:4163-4169.
33. Pawelec G., Barnett Y., Forsey R., Frasca D., Globerson A., McLeod J., Caruso C., Franceschi C., Fulop T., Gupta S., Mariani E., Mocchegiani E., Solana R. T cells, aging, January, 2002 update. Front. Biosci. 2002, 7:d1056-1183.
34. Kincade P., Medina K., Smithson G. Sex hormones as negative regulators of lymphopoiesis. Immunol. Rev. 1994, 137:119-134.